Patent litigation attorney

Chris L. Betti

1 tracked appearance — 0 plaintiff · 1 defendant.

Specialty & background

Christopher J. Betti, Ph.D., is a patent litigation attorney with a primary focus on biotechnology and pharmaceutical matters, particularly those involving biologics. His practice encompasses patent prosecution, patent litigation, and comprehensive intellectual property portfolio management. Dr. Betti offers strategic advice on complex patentability, validity, infringement, and freedom-to-operate issues. He also provides counseling related to the Biologics Price Competition and Innovation Act (BPCIA) and offers FDA regulatory guidance concerning biologics and pharmaceuticals, including Orange Book patent listings and patent term extensions.

Throughout his career, Dr. Betti has primarily represented technology companies and innovators, including defending against patent infringement allegations and in post-grant review proceedings. While his tracked appearance, Vision Works IP Corp. v. Jaguar Land Rover Automotive PLC, lists him as of counsel for the defendant with Alston & Bird in a case involving automotive technology, his broader professional profile highlights a focus on life sciences. Currently, Dr. Betti is a registered patent attorney at Morgan Lewis, having previously been a partner at K&L Gates where he led its biosimilars practice.

Dr. Betti has notable experience defending clients in contentious proceedings, including the successful defense of Nippon Shinyaku Co. against several Inter Partes Reviews (IPRs) that were ultimately dismissed by the Federal Circuit. He also represented Merck KGaA in an arbitration against NantKwest and Brink Biologics, successfully moving to dismiss a related district court action. His practice includes providing strategic direction for various post-grant matters, such as IPRs and ex-parte reexaminations, often in conjunction with co-pending patent litigation.

Dr. Betti earned his J.D. from Loyola University Chicago School of Law in 2005, and holds a Ph.D. in Molecular Biology (2002) and a B.S. (1996) from Loyola University Chicago and Benedictine University, respectively.

Firms

Roles

  • of counsel1

Cases (1)